$SYNA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SYNAPTICS Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in SYNAPTICS Inc. Get notifications about new insider transactions in SYNAPTICS Inc for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 07 2021 | SYNA | SYNAPTICS Inc | Awsare Saleel | See Remarks | Sell | S | 135.66 | 1,581 | 214,478 | 34,163 | 35.7 K to 34.2 K (-4.42 %) |
May 11 2021 | SYNA | SYNAPTICS Inc | Butler Dean Warren | See Remarks | Sell | S | 130.13 | 1,050 | 136,637 | 26,527 | 27.6 K to 26.5 K (-3.81 %) |
May 03 2021 | SYNA | SYNAPTICS Inc | Awsare Saleel | See Remarks | Payment of Exercise | F | 139.87 | 1,427 | 199,594 | 35,744 | 37.2 K to 35.7 K (-3.84 %) |
Apr 01 2021 | SYNA | SYNAPTICS Inc | Kumin Phillip Ralph | See Remarks | Payment of Exercise | F | 130.98 | 1,102 | 144,340 | 19,452 | 20.6 K to 19.5 K (-5.36 %) |
Feb 16 2021 | SYNA | SYNAPTICS Inc | Awsare Saleel | See Remarks | Sell | S | 128.89 | 1,700 | 219,113 | 37,045 | 38.7 K to 37 K (-4.39 %) |
Feb 16 2021 | SYNA | SYNAPTICS Inc | Awsare Saleel | See Remarks | Sell | S | 125.00 | 1,769 | 221,125 | 38,745 | 40.5 K to 38.7 K (-4.37 %) |
Feb 12 2021 | SYNA | SYNAPTICS Inc | CHAN NELSON C | Director | Option Exercise | M | 52.57 | 2,900 | 152,453 | 0 | |
Feb 12 2021 | SYNA | SYNAPTICS Inc | CHAN NELSON C | Director | Sell | S | 125.00 | 2,900 | 362,500 | 34,210 | 37.1 K to 34.2 K (-7.81 %) |
Feb 12 2021 | SYNA | SYNAPTICS Inc | CHAN NELSON C | Director | Buy | M | 52.57 | 2,900 | 152,453 | 37,110 | 34.2 K to 37.1 K (+8.48 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | M | 54.77 | 3,575 | 195,803 | 0 | |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | M | 54.36 | 3,575 | 194,337 | 0 | |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | M | 52.57 | 3,575 | 187,938 | 0 | |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | M | 51.95 | 2,725 | 141,564 | 0 | |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | M | 71.55 | 2,725 | 194,974 | 0 | |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | M | 73.31 | 2,725 | 199,770 | 0 | |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | M | 85.69 | 3,000 | 257,070 | 0 | |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | M | 76.81 | 3,000 | 230,430 | 0 | |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | M | 89.29 | 2,725 | 243,315 | 0 | |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | M | 79.38 | 3,000 | 238,140 | 0 | |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 123.02 | 7,722 | 949,934 | 14,860 | 22.6 K to 14.9 K (-34.20 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 122.59 | 4,328 | 530,574 | 22,582 | 26.9 K to 22.6 K (-16.08 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 121.41 | 1,400 | 169,971 | 26,910 | 28.3 K to 26.9 K (-4.95 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Buy | M | 54.77 | 3,575 | 195,803 | 28,310 | 24.7 K to 28.3 K (+14.45 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Buy | M | 54.36 | 3,575 | 194,337 | 24,735 | 21.2 K to 24.7 K (+16.90 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Buy | M | 52.57 | 3,575 | 187,938 | 21,160 | 17.6 K to 21.2 K (+20.33 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Buy | M | 51.95 | 2,725 | 141,564 | 17,585 | 14.9 K to 17.6 K (+18.34 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 121.47 | 4,211 | 511,496 | 14,860 | 19.1 K to 14.9 K (-22.08 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 120.43 | 1,674 | 201,606 | 19,071 | 20.7 K to 19.1 K (-8.07 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 118.66 | 8,190 | 971,826 | 20,745 | 28.9 K to 20.7 K (-28.30 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 117.47 | 3,100 | 364,154 | 28,935 | 32 K to 28.9 K (-9.68 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Buy | M | 71.55 | 2,725 | 194,974 | 32,035 | 29.3 K to 32 K (+9.30 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Buy | M | 73.31 | 2,725 | 199,770 | 29,310 | 26.6 K to 29.3 K (+10.25 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Buy | M | 85.69 | 3,000 | 257,070 | 26,585 | 23.6 K to 26.6 K (+12.72 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Buy | M | 76.81 | 3,000 | 230,430 | 23,585 | 20.6 K to 23.6 K (+14.57 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Buy | M | 89.29 | 2,725 | 243,315 | 20,585 | 17.9 K to 20.6 K (+15.26 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Buy | M | 79.38 | 3,000 | 238,140 | 17,860 | 14.9 K to 17.9 K (+20.19 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | WHIMS JAMES L | Director | Option Exercise | M | 62.11 | 2,400 | 149,052 | 0 | |
Feb 10 2021 | SYNA | SYNAPTICS Inc | WHIMS JAMES L | Director | Sell | S | 119.92 | 567 | 67,995 | 23,229 | 23.8 K to 23.2 K (-2.38 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | WHIMS JAMES L | Director | Sell | S | 118.45 | 3,433 | 406,628 | 23,796 | 27.2 K to 23.8 K (-12.61 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | WHIMS JAMES L | Director | Sell | S | 117.48 | 4,400 | 516,913 | 27,229 | 31.6 K to 27.2 K (-13.91 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | WHIMS JAMES L | Director | Buy | M | 62.11 | 2,400 | 149,052 | 31,629 | 29.2 K to 31.6 K (+8.21 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | CHAN NELSON C | Director | Option Exercise | M | 89.29 | 2,302 | 205,546 | 0 | |
Feb 10 2021 | SYNA | SYNAPTICS Inc | CHAN NELSON C | Director | Option Exercise | M | 62.11 | 2,400 | 149,052 | 0 | |
Feb 10 2021 | SYNA | SYNAPTICS Inc | CHAN NELSON C | Director | Sell | S | 123.00 | 2,302 | 283,146 | 34,210 | 36.5 K to 34.2 K (-6.30 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | CHAN NELSON C | Director | Sell | S | 120.18 | 2,400 | 288,427 | 36,512 | 38.9 K to 36.5 K (-6.17 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | CHAN NELSON C | Director | Buy | M | 89.29 | 2,302 | 205,546 | 38,912 | 36.6 K to 38.9 K (+6.29 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | CHAN NELSON C | Director | Buy | M | 62.11 | 2,400 | 149,052 | 36,610 | 34.2 K to 36.6 K (+7.02 %) |
Feb 09 2021 | SYNA | SYNAPTICS Inc | BUCHANAN JEFFREY D | Director | Option Exercise | M | 62.11 | 2,400 | 149,052 | 0 | |
Feb 09 2021 | SYNA | SYNAPTICS Inc | BUCHANAN JEFFREY D | Director | Sell | S | 119.92 | 2,400 | 287,808 | 10,148 | 12.5 K to 10.1 K (-19.13 %) |
Feb 09 2021 | SYNA | SYNAPTICS Inc | BUCHANAN JEFFREY D | Director | Buy | M | 62.11 | 2,400 | 149,052 | 12,548 | 10.1 K to 12.5 K (+23.65 %) |
Feb 09 2021 | SYNA | SYNAPTICS Inc | Awsare Saleel | See Remarks | Sell | S | 122.00 | 1,294 | 157,868 | 40,514 | 41.8 K to 40.5 K (-3.10 %) |
Feb 09 2021 | SYNA | SYNAPTICS Inc | Awsare Saleel | See Remarks | Sell | S | 122.04 | 500 | 61,020 | 41,808 | 42.3 K to 41.8 K (-1.18 %) |
Feb 09 2021 | SYNA | SYNAPTICS Inc | Butler Dean Warren | See Remarks | Sell | S | 119.92 | 1,050 | 125,916 | 27,484 | 28.5 K to 27.5 K (-3.68 %) |
Feb 02 2021 | SYNA | SYNAPTICS Inc | NOLAN KERMIT | See Remarks | Payment of Exercise | F | 99.22 | 2,075 | 205,882 | 35,636 | 37.7 K to 35.6 K (-5.50 %) |
Jan 06 2021 | SYNA | SYNAPTICS Inc | NOLAN KERMIT | See Remarks | Option Exercise | M | 89.29 | 1,049 | 93,665 | 0 | |
Jan 06 2021 | SYNA | SYNAPTICS Inc | NOLAN KERMIT | See Remarks | Sell | S | 100.00 | 1,049 | 104,900 | 37,711 | 38.8 K to 37.7 K (-2.71 %) |
Jan 06 2021 | SYNA | SYNAPTICS Inc | NOLAN KERMIT | See Remarks | Buy | M | 89.29 | 1,049 | 93,665 | 38,760 | 37.7 K to 38.8 K (+2.78 %) |
Jan 04 2021 | SYNA | SYNAPTICS Inc | NOLAN KERMIT | See Remarks | Option Exercise | M | 79.38 | 408 | 32,387 | 0 | |
Jan 04 2021 | SYNA | SYNAPTICS Inc | NOLAN KERMIT | See Remarks | Option Exercise | M | 85.69 | 408 | 34,962 | 0 | |
Jan 04 2021 | SYNA | SYNAPTICS Inc | NOLAN KERMIT | See Remarks | Sell | S | 95.00 | 7,261 | 689,795 | 37,711 | 45 K to 37.7 K (-16.15 %) |
Jan 04 2021 | SYNA | SYNAPTICS Inc | NOLAN KERMIT | See Remarks | Buy | M | 79.38 | 408 | 32,387 | 44,972 | 44.6 K to 45 K (+0.92 %) |
Jan 04 2021 | SYNA | SYNAPTICS Inc | NOLAN KERMIT | See Remarks | Buy | M | 85.69 | 408 | 34,962 | 44,564 | 44.2 K to 44.6 K (+0.92 %) |
Dec 29 2020 | SYNA | SYNAPTICS Inc | NOLAN KERMIT | See Remarks | Option Exercise | M | 78.11 | 745 | 58,192 | 0 | |
Dec 29 2020 | SYNA | SYNAPTICS Inc | NOLAN KERMIT | See Remarks | Sell | S | 90.00 | 5,745 | 517,050 | 44,156 | 49.9 K to 44.2 K (-11.51 %) |
Dec 29 2020 | SYNA | SYNAPTICS Inc | NOLAN KERMIT | See Remarks | Buy | M | 78.11 | 745 | 58,192 | 49,901 | 49.2 K to 49.9 K (+1.52 %) |
Dec 29 2020 | SYNA | SYNAPTICS Inc | BUCHANAN JEFFREY D | Director | Sell | S | 90.00 | 5,000 | 450,000 | 10,148 | 15.1 K to 10.1 K (-33.01 %) |
Nov 18 2020 | SYNA | SYNAPTICS Inc | Awsare Saleel | See Remarks | Sell | S | 79.60 | 139 | 11,064 | 42,308 | 42.4 K to 42.3 K (-0.33 %) |
Nov 10 2020 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 84.50 | 300 | 25,349 | 14,860 | 15.2 K to 14.9 K (-1.98 %) |
Nov 10 2020 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 83.38 | 4,383 | 365,473 | 15,160 | 19.5 K to 15.2 K (-22.43 %) |
Nov 10 2020 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 82.41 | 2,097 | 172,805 | 19,543 | 21.6 K to 19.5 K (-9.69 %) |
Nov 10 2020 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 81.60 | 3,695 | 301,511 | 21,640 | 25.3 K to 21.6 K (-14.58 %) |
Nov 10 2020 | SYNA | SYNAPTICS Inc | HARDMAN SUSAN J | Director | Sell | S | 83.50 | 376 | 31,396 | 3,955 | 4.3 K to 4 K (-8.68 %) |
Nov 10 2020 | SYNA | SYNAPTICS Inc | Awsare Saleel | See Remarks | Sell | S | 84.49 | 300 | 25,347 | 42,447 | 42.7 K to 42.4 K (-0.70 %) |
Nov 10 2020 | SYNA | SYNAPTICS Inc | Awsare Saleel | See Remarks | Sell | S | 83.43 | 3,112 | 259,648 | 42,747 | 45.9 K to 42.7 K (-6.79 %) |
Nov 10 2020 | SYNA | SYNAPTICS Inc | Awsare Saleel | See Remarks | Sell | S | 82.58 | 1,720 | 142,045 | 45,859 | 47.6 K to 45.9 K (-3.62 %) |
Nov 10 2020 | SYNA | SYNAPTICS Inc | Awsare Saleel | See Remarks | Sell | S | 81.61 | 3,364 | 274,528 | 47,579 | 50.9 K to 47.6 K (-6.60 %) |
Nov 10 2020 | SYNA | SYNAPTICS Inc | Allgood Kiva A. | Director | Sell | S | 83.50 | 300 | 25,050 | 8,026 | 8.3 K to 8 K (-3.60 %) |
Nov 10 2020 | SYNA | SYNAPTICS Inc | Butler Dean Warren | See Remarks | Sell | S | 84.49 | 200 | 16,898 | 28,534 | 28.7 K to 28.5 K (-0.70 %) |
Nov 10 2020 | SYNA | SYNAPTICS Inc | Butler Dean Warren | See Remarks | Sell | S | 83.43 | 2,233 | 186,294 | 28,734 | 31 K to 28.7 K (-7.21 %) |
Nov 10 2020 | SYNA | SYNAPTICS Inc | Butler Dean Warren | See Remarks | Sell | S | 82.61 | 1,942 | 160,420 | 30,967 | 32.9 K to 31 K (-5.90 %) |
Nov 10 2020 | SYNA | SYNAPTICS Inc | Butler Dean Warren | See Remarks | Sell | S | 81.66 | 2,939 | 239,989 | 32,909 | 35.8 K to 32.9 K (-8.20 %) |
Nov 04 2020 | SYNA | SYNAPTICS Inc | WHIMS JAMES L | Director | Grant | A | 0.00 | 2,467 | 0 | 29,229 | 26.8 K to 29.2 K (+9.22 %) |
Nov 04 2020 | SYNA | SYNAPTICS Inc | BUCHANAN JEFFREY D | Director | Grant | A | 0.00 | 2,467 | 0 | 15,148 | 12.7 K to 15.1 K (+19.45 %) |
Nov 04 2020 | SYNA | SYNAPTICS Inc | Allgood Kiva A. | Director | Grant | A | 0.00 | 2,467 | 0 | 8,326 | 5.9 K to 8.3 K (+42.11 %) |
Nov 03 2020 | SYNA | SYNAPTICS Inc | HURLSTON MICHAEL E. | See remarks below | Payment of Exercise | F | 76.67 | 6,424 | 492,528 | 267,362 | 273.8 K to 267.4 K (-2.35 %) |
Nov 03 2020 | SYNA | SYNAPTICS Inc | HURLSTON MICHAEL E. | See remarks below | Payment of Exercise | F | 76.67 | 12,846 | 984,903 | 273,786 | 286.6 K to 273.8 K (-4.48 %) |
Nov 03 2020 | SYNA | SYNAPTICS Inc | HURLSTON MICHAEL E. | See remarks below | Grant | A | 0.00 | 24,540 | 0 | 286,632 | 262.1 K to 286.6 K (+9.36 %) |
Nov 03 2020 | SYNA | SYNAPTICS Inc | Butler Dean Warren | See Remarks | Payment of Exercise | F | 76.67 | 7,137 | 547,194 | 35,848 | 43 K to 35.8 K (-16.60 %) |
Nov 03 2020 | SYNA | SYNAPTICS Inc | Butler Dean Warren | See Remarks | Grant | A | 0.00 | 13,634 | 0 | 42,985 | 29.4 K to 43 K (+46.45 %) |
Nov 03 2020 | SYNA | SYNAPTICS Inc | Awsare Saleel | See Remarks | Payment of Exercise | F | 76.67 | 5,023 | 385,113 | 50,943 | 56 K to 50.9 K (-8.98 %) |
Nov 03 2020 | SYNA | SYNAPTICS Inc | Awsare Saleel | See Remarks | Payment of Exercise | F | 76.67 | 5,231 | 401,061 | 55,966 | 61.2 K to 56 K (-8.55 %) |
Nov 03 2020 | SYNA | SYNAPTICS Inc | Awsare Saleel | See Remarks | Grant | A | 0.00 | 9,993 | 0 | 61,197 | 51.2 K to 61.2 K (+19.52 %) |
Nov 03 2020 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Payment of Exercise | F | 76.67 | 5,236 | 401,444 | 25,335 | 30.6 K to 25.3 K (-17.13 %) |
Nov 03 2020 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Payment of Exercise | F | 76.67 | 6,266 | 480,414 | 30,571 | 36.8 K to 30.6 K (-17.01 %) |
Nov 03 2020 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Grant | A | 0.00 | 11,971 | 0 | 36,837 | 24.9 K to 36.8 K (+48.14 %) |
Nov 03 2020 | SYNA | SYNAPTICS Inc | NOLAN KERMIT | See Remarks | Payment of Exercise | F | 76.67 | 3,323 | 254,774 | 49,156 | 52.5 K to 49.2 K (-6.33 %) |
Nov 03 2020 | SYNA | SYNAPTICS Inc | NOLAN KERMIT | See Remarks | Payment of Exercise | F | 76.67 | 2,175 | 166,757 | 52,479 | 54.7 K to 52.5 K (-3.98 %) |
Nov 03 2020 | SYNA | SYNAPTICS Inc | NOLAN KERMIT | See Remarks | Grant | A | 0.00 | 4,498 | 0 | 54,654 | 50.2 K to 54.7 K (+8.97 %) |
Oct 23 2020 | SYNA | SYNAPTICS Inc | Butler Dean Warren | See Remarks | Payment of Exercise | F | 78.98 | 2,685 | 212,061 | 29,351 | 32 K to 29.4 K (-8.38 %) |
Oct 13 2020 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 83.41 | 1,403 | 117,023 | 24,866 | 26.3 K to 24.9 K (-5.34 %) |
Oct 13 2020 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 82.92 | 7,811 | 647,718 | 26,269 | 34.1 K to 26.3 K (-22.92 %) |
Oct 09 2020 | SYNA | SYNAPTICS Inc | Kumin Phillip Ralph | See Remarks | Payment of Exercise | F | 81.66 | 1,443 | 117,835 | 20,159 | 21.6 K to 20.2 K (-6.68 %) |
Oct 09 2020 | SYNA | SYNAPTICS Inc | Kumin Phillip Ralph | See Remarks | Grant | A | 0.00 | 4,175 | 0 | 21,602 | 17.4 K to 21.6 K (+23.96 %) |
Oct 09 2020 | SYNA | SYNAPTICS Inc | HURLSTON MICHAEL E. | See remarks below | Payment of Exercise | F | 81.66 | 6,423 | 524,502 | 262,092 | 268.5 K to 262.1 K (-2.39 %) |
Oct 09 2020 | SYNA | SYNAPTICS Inc | HURLSTON MICHAEL E. | See remarks below | Grant | A | 0.00 | 12,270 | 0 | 268,515 | 256.2 K to 268.5 K (+4.79 %) |
Oct 09 2020 | SYNA | SYNAPTICS Inc | NOLAN KERMIT | See Remarks | Payment of Exercise | F | 81.66 | 2,213 | 180,714 | 50,156 | 52.4 K to 50.2 K (-4.23 %) |
Oct 09 2020 | SYNA | SYNAPTICS Inc | NOLAN KERMIT | See Remarks | Grant | A | 0.00 | 4,579 | 0 | 52,369 | 47.8 K to 52.4 K (+9.58 %) |
Oct 09 2020 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Payment of Exercise | F | 81.66 | 10,121 | 826,481 | 34,080 | 44.2 K to 34.1 K (-22.90 %) |
Oct 09 2020 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Grant | A | 0.00 | 19,335 | 0 | 44,201 | 24.9 K to 44.2 K (+77.76 %) |
Oct 09 2020 | SYNA | SYNAPTICS Inc | Butler Dean Warren | See Remarks | Payment of Exercise | F | 81.66 | 3,568 | 291,363 | 32,036 | 35.6 K to 32 K (-10.02 %) |
Oct 09 2020 | SYNA | SYNAPTICS Inc | Butler Dean Warren | See Remarks | Grant | A | 0.00 | 6,817 | 0 | 35,604 | 28.8 K to 35.6 K (+23.68 %) |
Oct 09 2020 | SYNA | SYNAPTICS Inc | Awsare Saleel | See Remarks | Payment of Exercise | F | 81.66 | 6,740 | 550,388 | 51,204 | 57.9 K to 51.2 K (-11.63 %) |
Oct 09 2020 | SYNA | SYNAPTICS Inc | Awsare Saleel | See Remarks | Grant | A | 0.00 | 12,878 | 0 | 57,944 | 45.1 K to 57.9 K (+28.58 %) |
Sep 25 2020 | SYNA | SYNAPTICS Inc | HURLSTON MICHAEL E. | See remarks below | Payment of Exercise | F | 78.34 | 17,176 | 1,345,568 | 256,245 | 273.4 K to 256.2 K (-6.28 %) |
Sep 25 2020 | SYNA | SYNAPTICS Inc | HURLSTON MICHAEL E. | See remarks below | Payment of Exercise | F | 78.34 | 4,057 | 317,825 | 273,421 | 277.5 K to 273.4 K (-1.46 %) |
Sep 25 2020 | SYNA | SYNAPTICS Inc | HURLSTON MICHAEL E. | See remarks below | Grant | A | 0.00 | 7,750 | 0 | 277,478 | 269.7 K to 277.5 K (+2.87 %) |
Aug 20 2020 | SYNA | SYNAPTICS Inc | HURLSTON MICHAEL E. | See remarks below | Payment of Exercise | F | 83.50 | 7,822 | 653,137 | 269,651 | 277.5 K to 269.7 K (-2.82 %) |
Aug 20 2020 | SYNA | SYNAPTICS Inc | HURLSTON MICHAEL E. | See remarks below | Payment of Exercise | F | 83.50 | 20,284 | 1,693,714 | 277,473 | 297.8 K to 277.5 K (-6.81 %) |
Aug 20 2020 | SYNA | SYNAPTICS Inc | HURLSTON MICHAEL E. | See remarks below | Grant | A | 0.00 | 38,747 | 0 | 297,757 | 259 K to 297.8 K (+14.96 %) |
Aug 19 2020 | SYNA | SYNAPTICS Inc | Kumin Phillip Ralph | See Remarks | Grant | A | 0.00 | 4,903 | 0 | 17,427 | 12.5 K to 17.4 K (+39.15 %) |
Aug 19 2020 | SYNA | SYNAPTICS Inc | Awsare Saleel | See Remarks | Grant | A | 0.00 | 6,844 | 0 | 44,814 | 38 K to 44.8 K (+18.02 %) |
Aug 19 2020 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Grant | A | 0.00 | 6,946 | 0 | 24,826 | 17.9 K to 24.8 K (+38.85 %) |
Aug 19 2020 | SYNA | SYNAPTICS Inc | HURLSTON MICHAEL E. | See remarks below | Grant | A | 0.00 | 30,648 | 0 | 259,010 | 228.4 K to 259 K (+13.42 %) |
Aug 19 2020 | SYNA | SYNAPTICS Inc | Butler Dean Warren | See Remarks | Grant | A | 0.00 | 7,764 | 0 | 28,487 | 20.7 K to 28.5 K (+37.47 %) |
Aug 19 2020 | SYNA | SYNAPTICS Inc | NOLAN KERMIT | See Remarks | Grant | A | 0.00 | 4,517 | 0 | 47,510 | 43 K to 47.5 K (+10.51 %) |
Aug 12 2020 | SYNA | SYNAPTICS Inc | WHIMS JAMES L | Director | Option Exercise | M | 46.50 | 4,500 | 209,250 | 0 | |
Aug 12 2020 | SYNA | SYNAPTICS Inc | WHIMS JAMES L | Director | Sell | S | 88.99 | 113 | 10,056 | 26,762 | 26.9 K to 26.8 K (-0.42 %) |
Aug 12 2020 | SYNA | SYNAPTICS Inc | WHIMS JAMES L | Director | Sell | S | 87.88 | 250 | 21,970 | 26,875 | 27.1 K to 26.9 K (-0.92 %) |
Aug 12 2020 | SYNA | SYNAPTICS Inc | WHIMS JAMES L | Director | Sell | S | 86.16 | 1,031 | 88,832 | 27,125 | 28.2 K to 27.1 K (-3.66 %) |
Aug 12 2020 | SYNA | SYNAPTICS Inc | WHIMS JAMES L | Director | Sell | S | 85.42 | 3,106 | 265,313 | 28,156 | 31.3 K to 28.2 K (-9.94 %) |
Aug 12 2020 | SYNA | SYNAPTICS Inc | WHIMS JAMES L | Director | Buy | M | 46.50 | 4,500 | 209,250 | 31,262 | 26.8 K to 31.3 K (+16.81 %) |
Aug 12 2020 | SYNA | SYNAPTICS Inc | SANQUINI RICHARD L | Director | Sell | S | 88.99 | 500 | 44,495 | 7,749 | 8.2 K to 7.7 K (-6.06 %) |
Aug 12 2020 | SYNA | SYNAPTICS Inc | SANQUINI RICHARD L | Director | Sell | S | 87.75 | 1,100 | 96,527 | 8,249 | 9.3 K to 8.2 K (-11.77 %) |
Aug 12 2020 | SYNA | SYNAPTICS Inc | SANQUINI RICHARD L | Director | Sell | S | 86.58 | 5,704 | 493,867 | 9,349 | 15.1 K to 9.3 K (-37.89 %) |
Aug 12 2020 | SYNA | SYNAPTICS Inc | NOLAN KERMIT | See Remarks | Option Exercise | M | 51.95 | 1,050 | 54,548 | 0 | |
Aug 12 2020 | SYNA | SYNAPTICS Inc | NOLAN KERMIT | See Remarks | Option Exercise | M | 71.55 | 1,049 | 75,056 | 0 | |
Aug 12 2020 | SYNA | SYNAPTICS Inc | NOLAN KERMIT | See Remarks | Option Exercise | M | 73.31 | 1,050 | 76,976 | 0 | |
Aug 12 2020 | SYNA | SYNAPTICS Inc | NOLAN KERMIT | See Remarks | Option Exercise | M | 76.81 | 408 | 31,338 | 0 | |
Aug 12 2020 | SYNA | SYNAPTICS Inc | NOLAN KERMIT | See Remarks | Option Exercise | M | 62.11 | 408 | 25,339 | 0 | |
Aug 12 2020 | SYNA | SYNAPTICS Inc | NOLAN KERMIT | See Remarks | Sell | S | 89.64 | 12 | 1,076 | 42,993 | 43 K to 43 K (-0.03 %) |
Aug 12 2020 | SYNA | SYNAPTICS Inc | NOLAN KERMIT | See Remarks | Sell | S | 88.93 | 377 | 33,526 | 43,005 | 43.4 K to 43 K (-0.87 %) |
Aug 12 2020 | SYNA | SYNAPTICS Inc | NOLAN KERMIT | See Remarks | Sell | S | 87.79 | 1,149 | 100,870 | 43,382 | 44.5 K to 43.4 K (-2.58 %) |
Aug 12 2020 | SYNA | SYNAPTICS Inc | NOLAN KERMIT | See Remarks | Sell | S | 86.21 | 2,369 | 204,226 | 44,531 | 46.9 K to 44.5 K (-5.05 %) |
Aug 12 2020 | SYNA | SYNAPTICS Inc | NOLAN KERMIT | See Remarks | Sell | S | 85.40 | 8,058 | 688,152 | 46,900 | 55 K to 46.9 K (-14.66 %) |
Aug 12 2020 | SYNA | SYNAPTICS Inc | NOLAN KERMIT | See Remarks | Buy | M | 51.95 | 1,050 | 54,548 | 54,958 | 53.9 K to 55 K (+1.95 %) |
Aug 12 2020 | SYNA | SYNAPTICS Inc | NOLAN KERMIT | See Remarks | Buy | M | 71.55 | 1,049 | 75,056 | 53,908 | 52.9 K to 53.9 K (+1.98 %) |
Aug 12 2020 | SYNA | SYNAPTICS Inc | NOLAN KERMIT | See Remarks | Buy | M | 73.31 | 1,050 | 76,976 | 52,859 | 51.8 K to 52.9 K (+2.03 %) |
Aug 12 2020 | SYNA | SYNAPTICS Inc | NOLAN KERMIT | See Remarks | Buy | M | 76.81 | 408 | 31,338 | 51,809 | 51.4 K to 51.8 K (+0.79 %) |
Aug 12 2020 | SYNA | SYNAPTICS Inc | NOLAN KERMIT | See Remarks | Buy | M | 62.11 | 408 | 25,339 | 51,401 | 51 K to 51.4 K (+0.80 %) |
Aug 12 2020 | SYNA | SYNAPTICS Inc | Awsare Saleel | See Remarks | Sell | S | 88.99 | 113 | 10,056 | 37,970 | 38.1 K to 38 K (-0.30 %) |